Page 2 - Processa Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Equities analysts predict that Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) will report earnings of ($0.24) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Processa Pharmaceuticals’ earnings. Processa Pharmaceuticals reported earnings per share of ($0.14) during the same quarter last year, which suggests a negative year […]

Wall Street brokerages expect Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Rating) to post earnings per share of ($0.18) for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Processa Pharmaceuticals’ earnings. Processa Pharmaceuticals reported earnings of ($0.90) per share in the same quarter last year, which indicates a positive year-over-year […]